Antiva Biosciences, founded in 2012, is a biopharmaceutical company most well known for their development of small molecule antivirals that improve health outcomes for patients suffering from diseases caused by HPV and other viruses. The company's antivirals are based on a medicinal chemistry platform that focuses on the development and commercialization of direct-acting antivirals for infections with the human papillomavirus, herpes group viruses, HIV and animal retroviruses. Antiva Biosciences is headquartered in South San Francisco, California.

Register for Details

For more details on financing and valuation for Antiva Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Antiva Biosciences's ticker symbol?

Antiva Biosciences does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Antiva Biosciences's stock price?

The stock price for Antiva Biosciences will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Who are Antiva Biosciences's major investors?

GV
Gaingels
Canaan Partners
Sofinnova Investments
Lumira Ventures
Mana Ventures
Adjuvant Capital
Avestria
BioImpact Capital
Alexandria

Learn more about Antiva Biosciences

Forge green plus iconForge green minus icon

When was Antiva Biosciences founded?

Antiva Biosciences was founded in 2012.
Forge green plus iconForge green minus icon

Can you invest in Antiva Biosciences?

Antiva Biosciences is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Antiva Biosciences share pre-IPO?

If you own Antiva Biosciences pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Antiva Biosciences a publicly traded company?

Antiva Biosciences is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Antiva Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$3.45B
Sector
Last Round Est. Valuation
$656.14MM
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$705.25MM
Sector
Last Round Est. Valuation
$1.15B
Sector
Last Round Est. Valuation
$1.22B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Updated on: May 3, 2023